ANDOVER EYE INSTITUTE

Serial Number 98593465
641

Registration Progress

Application Filed
Jun 10, 2024
Under Examination
Approved for Publication
Published for Opposition
Registered

Attorney Assistance

Non-Final Action Mailed
Due: Jul 23, 2025 8 days

Trademark Image

ANDOVER EYE INSTITUTE

Basic Information

Serial Number
98593465
Filing Date
June 10, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
641
Status Date
Apr 23, 2025
Application
Pending
Classes
035 042

Rights Holder

Andover Eye Associates, Inc.

03
Address
138 Haverhill Street
Suite 104
Andover, MA 01810

Ownership History

Andover Eye Associates, Inc.

Original Applicant
03
Andover, MA

Legal Representation

Attorney
Michael R Rizzo

USPTO Deadlines

Next Deadline
8 days remaining
Non-Final Action Mailed
Due Date
July 23, 2025
Extension Available
Until October 23, 2025
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

14 events
Date Code Type Description Documents
Apr 23, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Apr 23, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Apr 23, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Apr 17, 2025 IUAA P USE AMENDMENT ACCEPTED Loading...
Mar 27, 2025 AUPC I AMENDMENT TO USE PROCESSING COMPLETE Loading...
Mar 27, 2025 IUAF S USE AMENDMENT FILED Loading...
Mar 27, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 27, 2025 EAAU I TEAS AMENDMENT OF USE RECEIVED Loading...
Dec 28, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Dec 28, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Dec 28, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Dec 27, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 26, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 10, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 035
Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; compilation and analysis of biostatistics for business or commercial purposes
First Use Anywhere: Jun 22, 2024
First Use in Commerce: Jun 22, 2024
Class 042
Medical and scientific research, namely, conducting clinical trials for others; pharmaceutical drug development services; pharmaceutical testing services
First Use Anywhere: Jun 22, 2024
First Use in Commerce: Jun 22, 2024

Classification

International Classes
035 042